
Carla Palm
Carla Palm is a journalist known for her insightful reporting on business and economic trends. Her recent article discusses the resilience and growth potential of the Swiss sanitary company Geberit amidst challenging market conditions, highlighting the company's innovative products and strategic initiatives.
Not in the pool (under ¢1).
Recent news mentions
Carla Palm reported on the challenges faced by Sika due to various market conditions.
Sika trotzt dem GegenwindCarla Palm is the author of the article discussing the transformation of Georg Fischer and the market position of Geberit.
Geberit oder Georg Fischer?Carla Palm reported on the challenges faced by the lab equipment supplier Tecan.
Für einen Einstieg ist es noch zu frühCarla Palm reports on the developments in the hearing aid market and the impact of EssilorLuxottica's new product.
Weckruf für Sonova: der Tesla-Moment im Hörgeräte-MarktCarla Palm is mentioned in the context of Swiss companies affected by the dollar's weakness.
Welche Schweizer Unternehmen die Dollarschwäche zu spüren bekommenCarla Palm is the author of the article discussing the impact of US tariff policies on Swiss fund managers.
«Wir trauen Lonza eine deutliche Erholung zu»Carla Palm is mentioned alongside Manuel Boeck in the context of Barry Callebaut's challenges.
Kommentar zu SGS, Barry Callebaut, Tecan, R&S und SPSCarla Palm reported on the challenges facing ABB Robotics in the stock market.
ABB Robotics dürfte es an der Börse schwer habenCarla Palm is mentioned as one of the authors of the article.
Börsenkommentar zu Holcim, Amrize, Nestlé, Huber+Suhner, Burkhalter und YpsomedCarla Palm reported on the challenges faced by Logitech in a complicated market environment.
Logitech steckt in der ZwickmühleCarla Palm reported on the growth potential of Sika in the construction chemicals sector.
Sika sind ein Kauf
Carla Palm is mentioned as part of the sign-off in the article.
Mr Market zu Aryzta, Idorsia, Kühne + Nagel, Tecan und DKSHCarla Palm reports on the financial performance and market position of Belimo.
Belimo bleibt kaufenswertCarla Palm discusses the challenges faced by the Swiss Medtech industry due to the US market conditions.
Medtech-Anleger brauchen GeduldCarla Palm is mentioned as part of the closing remarks in the article.
Börsenkommentar zu Lindt, Logitech, VAT, SGS und Meier ToblerCarla Palm is the author of the article discussing Geberit's market position and financial outlook.
Geberit gehört ins Portfolio






















































